Hydrocephalus Shunts Market is expected to reach US$ 360.01 Million by 2028

Hydrocephalus Valves Segment to Dominate Hydrocephalus Shunts Market

According to our new research study, titled "Hydrocephalus Shunts Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Type, Age Group, and End User," the hydrocephalus shunts market was valued US$ 286.19 million in 2021; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028. The market growth is primarily attributed to the increasing prevalence of hydrocephalus and advancements in hydrocephalus valves. However, the high cost of treatment involving shunts and the need for revision surgeries are hindering the growth of the market.

Based on type, the hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritoneal. The ventriculo-peritoneal segment held the largest share of the market in 2021, and it is further anticipated to register the highest CAGR during the forecast period. According to the research paper published in the National Center for Biotechnology Information (NCBI), a ventriculo-peritoneal shunt is a highly impacted in neurosurgical patient care. This shunt can be lifesaving for benign disorders, and it is known for a good outcome among many patients.

Hydrocephalus Shunts Market, by Region, 2021 (%)

Source: The Insight Partners Analysis

According to the Hydrocephalus Association, hydrocephalus affects over 1 million Americans. Additionally, the incidence rate of the disease in the US is 1 in every 770 babies. According to the article "Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis," published in the Journal of Neurosurgery (JNS) in 2019, low-income and middle-income countries, particularly those in Africa and Latin America, experience the most significant burden of hydrocephalus. The article also states that Sub-Saharan Africa witnessed an annual incidence of more than 225,000 new cases of infant hydrocephalus, i.e., 750 new cases per 100,000 live births. Moreover, in a European cohort, the incidence rate was estimated at 110 cases of infantile hydrocephalus per 100,000 live births. The treatment approach of hydrocephalus highly focuses on managing CSF through medical devices named shunts. The shunt systems remove excess cerebrospinal fluid from the brain and divert it to other body parts, wherein it is absorbed as a part of the circulatory process.

B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); Sophysa; HpBio Próteses, inc.; Integra LifeSciences Holdings Corporation; KANEKA MEDIX CORP.; Medtronic; Natus Medical Incorporated; Spiegelberg GmbH & Co. KG; and Desu Medical are the key companies operating in the hydrocephalus shunts market.

The report segments the hydrocephalus shunts market as follows:

The hydrocephalus shunts market is segmented on the basis of product, type, age group, end user, and geography. Based on product, the market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The market for hydrocephalus valves is further segmented into adjustable pressure valves and fixed pressure valves. Based on type, the hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritoneal. Based on age group, the market is bifurcated into pediatric and adults. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others.

On the basis of geography, the hydrocephalus shunts market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com